尿路上皮癌中免疫细胞的预后影响与空间相互作用
研究对2463例尿路上皮膀胱癌组织芯片进行21种抗体多重荧光免疫组化染色,用神经网络框架分析免疫细胞空间参数与预后。发现39个免疫参数有预后意义,其中16个在肌层浸润性膀胱癌中独立于pT、pN和组织学分级。上皮内CD8+细胞毒性T细胞密度是与总生存期关联最强的特征(AUC 0.70),间质CD8+ T细胞相关性较弱(AUC 0.65)。
要点
- 上皮内CD8+细胞毒性T细胞密度是肌层浸润性膀胱癌最强的预后特征(AUC 0.70)。
- 间质CD8+ T细胞预后相关性较弱(AUC 0.65)。
- 39个免疫参数有预后意义,16个独立于pT、pN和组织学分级。
核心结论
- 上皮内CD8+ T细胞密度是肌层浸润性膀胱癌最强的预后特征。
- 肿瘤细胞邻近CD8+ T细胞数量可能作为免疫系统识别癌症效率的替代指标,可在常规病理中直接以CD8标记指数测量。
研究设计与样本
- 对2463例尿路上皮膀胱癌组织芯片进行21种抗体的BLEACH&STAIN多重荧光免疫组化染色,并用神经网络框架进行图像分析。
- 将空间免疫参数与组织病理学参数和总生存期数据进行比较。
主要发现
- 识别出超过300种不同的免疫细胞亚群并刻画其空间关系,得到众多空间相互作用模式。
- 39个免疫参数在单变量分析中有预后意义,其中16个在肌层浸润性膀胱癌中独立于pT、pN和组织学分级。
- 与总生存期延长关联最强的是上皮内CD8+细胞毒性T细胞(时间依赖AUC 0.70),间质CD8+ T细胞相关性较弱(AUC 0.65)。
- 高表达「耗竭标志物」的炎症型癌症预后良好,提示免疫细胞上的TIM3、PD-L1、PD-1和CTLA-4在富含肿瘤浸润免疫细胞的肿瘤中不阻碍抗肿瘤免疫应答。
临床怎么用
- 上皮内CD8+ T细胞定量可通过明场免疫组化轻松评估,因此「 ready to use 」用于常规病理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Quantity and the spatial relationship of specific immune cell types can provide prognostic information in bladder cancer. The objective of the study was to characterize the spatial interplay and prognostic role of different immune cell subpopulations in bladder cancer. METHODS: A total of 2463 urothelial bladder carcinomas were immunostained with 21 antibodies using BLEACH&STAIN multiplex fluorescence immunohistochemistry in a tissue microarray format and analyzed using a framework of neuronal networks for an image analysis. Spatial immune parameters were compared with histopathological parameters and overall survival data. KEY FINDINGS AND LIMITATIONS: The identification of > 300 different immune cell subpopulations and the characterization of their spatial relationship resulted in numerous spatial interaction patterns. Thirty-nine immune parameters showed prognostic significance in univariate analyses, of which 16 were independent from pT, pN, and histological grade in muscle-invasive bladder cancer. Among all these parameters, the strongest association with prolonged overall survival was identified for intraepithelial CD8+ cytotoxic T cells (time-dependent area under receiver operating characteristic curve [AUC]: 0.70), while stromal CD8+ T cells were less relevant (AUC: 0.65). A favorable prognosis of inflamed cancers with high levels of "exhaustion markers" suggests that TIM3, PD-L1, PD-1, and CTLA-4 on immune cells do not hinder antitumoral immune response in tumors rich of tumor infiltrating immune cells. CONCLUSIONS AND CLINICAL IMPLICATIONS: The density of intraepithelial CD8+ T cells was the strongest prognostic feature in muscle-invasive bladder cancer. Given that tumor cell killing by CD8+ cytotoxic T lymphocytes through direct cell-to-cell-contacts represents the "terminal end route" of antitumor immunity, the quantity of "tumor cell adjacent CD8+ T cells" may constitute a surrogate for the efficiency of cancer recognition by the immune system that can be measured straightaway in routine pathology as the CD8 labeling index. PATIENT SUMMARY: Quantification of intraepithelial CD8+ T cells, the strongest prognosticfeature identified in muscle-invasive bladder cancer, can easily be assessed by brightfield immunohistochemistry and is therefore "ready to use" for routine pathology.
引用
- Debatin NF, Bady E, Mandelkow T, et al. Prognostic Impact and Spatial Interplay of Immune Cells in Urothelial Cancer. Eur Urol. 2024. PMID: 38383257. doi:10.1016/j.eururo.2024.01.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。